Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 47

Related Articles by Review for PubMed (Select 17893871)

1.

Downregulation of PAR-4, a pro-apoptotic gene, in pancreatic tumors harboring K-ras mutation.

Ahmed MM, Sheldon D, Fruitwala MA, Venkatasubbarao K, Lee EY, Gupta S, Wood C, Mohiuddin M, Strodel WE.

Int J Cancer. 2008 Jan 1;122(1):63-70.

PMID:
17893871
2.

Mutational activation of the c-K-ras gene in human pancreatic carcinoma.

Shibata D, Capella G, Perucho M.

Baillieres Clin Gastroenterol. 1990 Mar;4(1):151-69. Review.

PMID:
1976394
3.

K-ras p21 expression and activity in lung and lung tumors.

Ramakrishna G, Sithanandam G, Cheng RY, Fornwald LW, Smith GT, Diwan BA, Anderson LM.

Exp Lung Res. 2000 Dec;26(8):659-71. Review.

PMID:
11195463
4.

Oligonucleotide treatment of ras-induced tumors in nude mice.

Wickstrom E.

Mol Biotechnol. 2001 May;18(1):35-55. Review.

PMID:
11439698
5.

K-Ras mutations and benign pancreatic disease.

Löhr M, Maisonneuve P, Lowenfels AB.

Int J Pancreatol. 2000 Apr;27(2):93-103. Review.

PMID:
10862508
6.

Mutant KRAS in the initiation of pancreatic cancer.

Deramaudt T, Rustgi AK.

Biochim Biophys Acta. 2005 Nov 25;1756(2):97-101. Epub 2005 Sep 7. Review.

PMID:
16169155
7.

Molecular pattern of ductal pancreatic cancer.

Sirivatanauksorn V, Sirivatanauksorn Y, Lemoine NR.

Langenbecks Arch Surg. 1998 Apr;383(2):105-15. Review.

PMID:
9641882
8.

ras and human tumors.

Rodenhuis S.

Semin Cancer Biol. 1992 Aug;3(4):241-7. Review.

PMID:
1421168
9.

Values of mutations of K-ras oncogene at codon 12 in detection of pancreatic cancer: 15-year experience.

Mu DQ, Peng YS, Xu QJ.

World J Gastroenterol. 2004 Feb 15;10(4):471-5. Review.

10.

The genetics of pancreatic cancer.

Cowgill SM, Muscarella P.

Am J Surg. 2003 Sep;186(3):279-86. Review.

PMID:
12946833
11.

[Molecular pathways of pancreatic carcinogenesis].

Torrisani J, Buscail L.

Ann Pathol. 2002 Oct;22(5):349-55. Review. French.

PMID:
12483152
12.

Shh signaling and pancreatic cancer: implications for therapy?

Morton JP, Lewis BC.

Cell Cycle. 2007 Jul 1;6(13):1553-7. Epub 2007 May 18. Review.

13.

[Mutant K-ras gene in pathogenesis of pancreatic ductal adenocarcinoma].

Guan J, Chen J.

Zhonghua Bing Li Xue Za Zhi. 2012 Jan;41(1):62-5. Review. Chinese. No abstract available.

PMID:
22455858
14.

Reactive oxygen species and lung tumorigenesis by mutant K-ras: a working hypothesis.

Maciag A, Anderson LM.

Exp Lung Res. 2005 Jan-Feb;31(1):83-104. Review.

PMID:
15765920
15.

Recent discoveries in cancer genetics of exocrine pancreatic neoplasia.

Hahn SA, Schmiegel WH.

Digestion. 1998 Aug;59(5):493-501. Review.

PMID:
9705534
16.

Pancreatic cancer--new aspects of molecular biology research.

Kleeff J, Friess H, Berberat PO, Martignoni ME, Z'graggen K, Büchler MW.

Swiss Surg. 2000;6(5):231-4. Review.

PMID:
11077487
17.

Molecular biology of exocrine pancreatic cancer.

Soto JL, Barbera VM, Saceda M, Carrato A.

Clin Transl Oncol. 2006 May;8(5):306-12. Review.

PMID:
16760004
18.

Mouse models of K-ras-initiated carcinogenesis.

Janssen KP, Abal M, El Marjou F, Louvard D, Robine S.

Biochim Biophys Acta. 2005 Nov 25;1756(2):145-54. Epub 2005 Aug 8. Review. Erratum in: Biochim Biophys Acta. 2006 Apr;1765(2):256. Abala, Miguel [corrected to Abal, Miguel].

PMID:
16126346
19.

K-ras as a target for cancer therapy.

Friday BB, Adjei AA.

Biochim Biophys Acta. 2005 Nov 25;1756(2):127-44. Epub 2005 Aug 18. Review.

PMID:
16139957
20.

Molecular epidemiology of pancreatic cancer.

Li D.

Cancer J. 2001 Jul-Aug;7(4):259-65. Review.

PMID:
11561602
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk